The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure

• Margrethe Flesvig Holt,
• Margrethe Flesvig Holt,
• Annika E. Michelsen,
• Annika E. Michelsen,
• Negar Shahini,
• Elisabeth Bjørkelund,
• Christina Holt Bendz,
• Richard J. Massey,
• Richard J. Massey,
• Camilla Schjalm,
• Bente Halvorsen,
• Bente Halvorsen,
• Kaspar Broch,
• Kaspar Broch,
• Thor Ueland,
• Thor Ueland,
• Thor Ueland,
• Lars Gullestad,
• Lars Gullestad,
• Lars Gullestad,
• Per H. Nilsson,
• Per H. Nilsson,
• Pål Aukrust,
• Pål Aukrust,
• Pål Aukrust,
• Tom Eirik Mollnes,
• Tom Eirik Mollnes,
• Tom Eirik Mollnes,
• Tom Eirik Mollnes,
• Mieke C. Louwe

Affiliations

Margrethe Flesvig Holt

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

Margrethe Flesvig Holt

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Annika E. Michelsen

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

Annika E. Michelsen

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Negar Shahini

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

Elisabeth Bjørkelund

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Christina Holt Bendz

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Richard J. Massey

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Richard J. Massey

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Camilla Schjalm

Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway

Bente Halvorsen

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

Bente Halvorsen

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Kaspar Broch

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Kaspar Broch

K.G. Jebsen Cardiac Research Center, Center for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway

Thor Ueland

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

Thor Ueland

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Thor Ueland

Faculty of Health Sciences, K. G. Jebsen Thrombosis Research Center, University of Tromsø – The Arctic University of Norway, Tromsø, Norway

Lars Gullestad

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Lars Gullestad

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Lars Gullestad

K.G. Jebsen Cardiac Research Center, Center for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway

Per H. Nilsson

Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway

Per H. Nilsson

Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden

Pål Aukrust

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

Pål Aukrust

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Pål Aukrust

Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway

Tom Eirik Mollnes

Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway

Tom Eirik Mollnes

Faculty of Health Sciences, K. G. Jebsen Thrombosis Research Center, University of Tromsø – The Arctic University of Norway, Tromsø, Norway

Tom Eirik Mollnes

Research Laboratory, Nordland Hospital, Bodø, Norway

Tom Eirik Mollnes

0Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway

Mieke C. Louwe

Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway